<p>Aveanna Healthcare（纳斯达克代码：AVAH - 获取免费报告）于周四公布了季度财报。该公司报告本季度每股收益（EPS）为 0.15 美元，超出市场共识预期的 0.07 美元，超出幅度为 0.08 美元，FiscalAI 报道。该公司本季度的收入为 6.2194 亿美元，而分析师预期为 5.7857 亿美元。Aveanna Healthcare 的净利润率为 3.29%，股本回报率为负 103.46%。Aveanna Healthcare 更新了其 2025 财年的每股收益指引。</p>
<p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
<h2>Aveanna Healthcare 价格表现</h2>
<p>周五，AVAH 的交易价格上涨 0.12 美元，达到 8.75 美元。该公司的交易量为 1,381,278 股，而其平均交易量为 1,771,923 股。该公司的市值为 18.3 亿美元，市盈率为 24.31，贝塔值为 2.04。Aveanna Healthcare 的 12 个月低点为 3.67 美元，12 个月高点为 10.32 美元。该公司的 50 日移动平均价格为 8.86 美元，200 日移动平均价格为 6.48 美元。</p>
<h2>分析师评级调整</h2>
<p>多家股票分析师最近对该公司进行了评估。瑞银集团将 Aveanna Healthcare 的目标价从 9.00 美元上调至 9.50 美元，并在周五的研究报告中给予该公司 “中性” 评级。雷蒙德·詹姆斯金融公司将 Aveanna Healthcare 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 8 月 11 日的研究报告中设定了 9.00 美元的目标价。韦斯评级在 10 月 8 日的研究报告中重新发布了对 Aveanna Healthcare 股票的 “持有（c）” 评级。巴克莱将 Aveanna Healthcare 的评级从 “等权重” 上调至 “超配”，并在 8 月 19 日的报告中将该股票的目标价从 5.50 美元上调至 9.50 美元。最后，加拿大皇家银行在 10 月 24 日的报告中将 Aveanna Healthcare 的目标价从 8.00 美元上调至 10.00 美元，并给予该公司 “行业表现” 评级。三位股票研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价为 10.07 美元。</p>
<p><strong>阅读我们对 Aveanna Healthcare 的最新分析</strong></p>
<h2>Aveanna Healthcare 的内部活动</h2>
<p>在相关消息中，主要股东 Robert M. Williams, Jr.于 10 月 24 日周五出售了 1,500,000 股公司的股票。股票以平均价格 9.00 美元出售，总价值为 13,500,000.00 美元。交易完成后，该内部人士直接持有 362,746 股公司的股票，估值约为 3,264,714 美元。这代表其持股比例减少了 80.53%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接访问。此外，主要股东 Paul R. Vigano 于 10 月 24 日周五出售了 1,500,000 股股票。该股票以平均价格 9.00 美元出售，总价值为 13,500,000.00 美元。交易完成后，该内部人士持有 362,746 股公司的股票，估值约为 3,264,714 美元。这笔交易代表其持股比例减少了 80.53%。该出售的披露信息可在 SEC 文件中找到。在过去的九十天里，内部人士已出售 32,597,968 股公司股票，价值为 293,381,712 美元。7.80% 的股票由公司内部人士持有。</p>
<h2>机构投资者对 Aveanna Healthcare 的看法</h2>
<p>几家对冲基金和其他机构投资者最近增加或减少了对 AVAH 的持股。先锋集团在第三季度将其在 Aveanna Healthcare 的股份增加了 34.7%。先锋集团目前持有 4,041,659 股公司股票，价值为 35,850,000 美元，此前在上个季度又购买了 1,041,324 股。Squarepoint Ops LLC 在第二季度将其在 Aveanna Healthcare 的持股增加了 207.0%。Squarepoint Ops LLC 目前持有 479,977 股公司股票，价值为 2,510,000 美元，此前在上个季度又购买了 323,656 股。Qube Research &amp; Technologies Ltd 在第二季度将其在 Aveanna Healthcare 的持股增加了 92.4%。Qube Research &amp; Technologies Ltd 目前持有 437,838 股公司股票，价值为 2,290,000 美元，此前在上个季度又购买了 210,288 股。Lazard Asset Management LLC 在第二季度收购了 Aveanna Healthcare 的新股份，价值约为 791,000 美元。最后，Ameriprise Financial Inc.在第二季度将其在 Aveanna Healthcare 的持股增加了 168.0%。Ameriprise Financial Inc.目前持有 145,982 股公司股票，价值为 763,000 美元，此前在上个季度又购买了 91,508 股。87.96% 的股票目前由机构投资者和对冲基金持有。</p>
<h2>Aveanna Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Aveanna Healthcare Holdings Inc 是一家多元化的居家护理平台公司，在美国提供儿童和成人医疗服务。其以患者为中心的护理交付平台使患者能够留在家中，减少对高成本护理环境（如医院或专业护理机构）的过度使用。</p>
<h2>推荐阅读</h2>
<ul>
<li>我们更看好的五只股票超过 Aveanna Healthcare</li>
<li>商业服务股票投资</li>
<li>分析师认为 e.l.f.的抛售是一个良好的买入时机</li>
<li>关于 Markup 计算器</li>
<li>T-Mobile 是最被低估的大型股——是买入时机吗？</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克将何时关闭</li>
<li>高通财报让华尔街感到惊讶——第四季度可能会带来什么</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
<p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄向客户推荐在更广泛的市场注意到之前购买……而 Aveanna Healthcare 并不在名单上。</p>
<p>虽然 Aveanna Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AVAH

<p>Aveanna Healthcare（纳斯达克代码：AVAH）报告本季度每股收益为 0.15 美元，超出预期的 0.07 美元。收入达到 6.2194 亿美元，超过预期的 5.7857 亿美元。该公司的股本回报率为负 103.46%，净利润率为 3.29%。Aveanna 更新了 2025 财年的指引。分析师的评级不一，目标价格范围在 9.00 美元到 10.00 美元之间。近期内部人士出售了 3260 万股，机构投资者已增加在该公司的持股</p>

<p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.08, FiscalAI reports. The company had revenue of $621.94 million for the quarter, compared to analysts' expectations of $578.57 million. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 103.46%. Aveanna Healthcare updated its FY 2025 guidance to EPS.</p>
<div class="lb-trans"><p>Aveanna Healthcare（纳斯达克代码：AVAH - 获取免费报告）于周四公布了季度财报。该公司报告本季度每股收益（EPS）为 0.15 美元，超出市场共识预期的 0.07 美元，超出幅度为 0.08 美元，FiscalAI 报道。该公司本季度的收入为 6.2194 亿美元，而分析师预期为 5.7857 亿美元。Aveanna Healthcare 的净利润率为 3.29%，股本回报率为负 103.46%。Aveanna Healthcare 更新了其 2025 财年的每股收益指引。</p>
</div><p>Get <strong>Aveanna Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Aveanna Healthcare</strong> 的提醒：</p>
</div><h2>Aveanna Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 价格表现</h2>
</div><p>AVAH traded up $0.12 during trading on Friday, reaching $8.75. The company had a trading volume of 1,381,278 shares, compared to its average volume of 1,771,923. The company has a market cap of $1.83 billion, a P/E ratio of 24.31 and a beta of 2.04. Aveanna Healthcare has a 12 month low of $3.67 and a 12 month high of $10.32. The business's fifty day moving average price is $8.86 and its 200 day moving average price is $6.48.</p>
<div class="lb-trans"><p>周五，AVAH 的交易价格上涨 0.12 美元，达到 8.75 美元。该公司的交易量为 1,381,278 股，而其平均交易量为 1,771,923 股。该公司的市值为 18.3 亿美元，市盈率为 24.31，贝塔值为 2.04。Aveanna Healthcare 的 12 个月低点为 3.67 美元，12 个月高点为 10.32 美元。该公司的 50 日移动平均价格为 8.86 美元，200 日移动平均价格为 6.48 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>A number of equities analysts recently weighed in on the company. UBS Group increased their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the company a &#34;neutral&#34; rating in a research report on Friday. Raymond James Financial raised Aveanna Healthcare from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $9.00 price target for the company in a research note on Monday, August 11th. Weiss Ratings reissued a &#34;hold (c)&#34; rating on shares of Aveanna Healthcare in a research report on Wednesday, October 8th. Barclays upgraded Aveanna Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and boosted their target price for the stock from $5.50 to $9.50 in a report on Tuesday, August 19th. Finally, Royal Bank Of Canada increased their price target on Aveanna Healthcare from $8.00 to $10.00 and gave the company a &#34;sector perform&#34; rating in a report on Friday, October 24th. Three equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of &#34;Hold&#34; and a consensus price target of $10.07.</p>
<div class="lb-trans"><p>多家股票分析师最近对该公司进行了评估。瑞银集团将 Aveanna Healthcare 的目标价从 9.00 美元上调至 9.50 美元，并在周五的研究报告中给予该公司 “中性” 评级。雷蒙德·詹姆斯金融公司将 Aveanna Healthcare 的评级从 “市场表现” 上调至 “跑赢大盘”，并在 8 月 11 日的研究报告中设定了 9.00 美元的目标价。韦斯评级在 10 月 8 日的研究报告中重新发布了对 Aveanna Healthcare 股票的 “持有（c）” 评级。巴克莱将 Aveanna Healthcare 的评级从 “等权重” 上调至 “超配”，并在 8 月 19 日的报告中将该股票的目标价从 5.50 美元上调至 9.50 美元。最后，加拿大皇家银行在 10 月 24 日的报告中将 Aveanna Healthcare 的目标价从 8.00 美元上调至 10.00 美元，并给予该公司 “行业表现” 评级。三位股票研究分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，共识目标价为 10.07 美元。</p>
</div><p><strong>Read Our Latest Analysis on Aveanna Healthcare</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 Aveanna Healthcare 的最新分析</strong></p>
</div><h2>Insider Activity at Aveanna Healthcare</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 的内部活动</h2>
</div><p>In related news, major shareholder Robert M. Williams, Jr. sold 1,500,000 shares of the company's stock in a transaction on Friday, October 24th. The shares were sold at an average price of $9.00, for a total value of $13,500,000.00. Following the completion of the transaction, the insider directly owned 362,746 shares of the company's stock, valued at approximately $3,264,714. This represents a 80.53% decrease in their position. The sale was disclosed in a document filed with the Securities &amp; Exchange Commission, which is accessible through this link. Also, major shareholder Paul R. Vigano sold 1,500,000 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $9.00, for a total value of $13,500,000.00. Following the transaction, the insider owned 362,746 shares of the company's stock, valued at approximately $3,264,714. This trade represents a 80.53% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 32,597,968 shares of company stock valued at $293,381,712. 7.80% of the stock is owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，主要股东 Robert M. Williams, Jr.于 10 月 24 日周五出售了 1,500,000 股公司的股票。股票以平均价格 9.00 美元出售，总价值为 13,500,000.00 美元。交易完成后，该内部人士直接持有 362,746 股公司的股票，估值约为 3,264,714 美元。这代表其持股比例减少了 80.53%。该出售在向证券交易委员会提交的文件中披露，文件可通过此链接访问。此外，主要股东 Paul R. Vigano 于 10 月 24 日周五出售了 1,500,000 股股票。该股票以平均价格 9.00 美元出售，总价值为 13,500,000.00 美元。交易完成后，该内部人士持有 362,746 股公司的股票，估值约为 3,264,714 美元。这笔交易代表其持股比例减少了 80.53%。该出售的披露信息可在 SEC 文件中找到。在过去的九十天里，内部人士已出售 32,597,968 股公司股票，价值为 293,381,712 美元。7.80% 的股票由公司内部人士持有。</p>
</div><h2>Institutional Investors Weigh In On Aveanna Healthcare</h2>
<div class="lb-trans"><h2>机构投资者对 Aveanna Healthcare 的看法</h2>
</div><p>Several hedge funds and other institutional investors have recently added to or reduced their stakes in AVAH. Vanguard Group Inc. boosted its stake in shares of Aveanna Healthcare by 34.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company's stock worth $35,850,000 after buying an additional 1,041,324 shares during the last quarter. Squarepoint Ops LLC increased its position in shares of Aveanna Healthcare by 207.0% during the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company's stock worth $2,510,000 after purchasing an additional 323,656 shares during the last quarter. Qube Research &amp; Technologies Ltd raised its stake in shares of Aveanna Healthcare by 92.4% during the 2nd quarter. Qube Research &amp; Technologies Ltd now owns 437,838 shares of the company's stock worth $2,290,000 after purchasing an additional 210,288 shares in the last quarter. Lazard Asset Management LLC acquired a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at approximately $791,000. Finally, Ameriprise Financial Inc. grew its stake in shares of Aveanna Healthcare by 168.0% in the second quarter. Ameriprise Financial Inc. now owns 145,982 shares of the company's stock valued at $763,000 after buying an additional 91,508 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>几家对冲基金和其他机构投资者最近增加或减少了对 AVAH 的持股。先锋集团在第三季度将其在 Aveanna Healthcare 的股份增加了 34.7%。先锋集团目前持有 4,041,659 股公司股票，价值为 35,850,000 美元，此前在上个季度又购买了 1,041,324 股。Squarepoint Ops LLC 在第二季度将其在 Aveanna Healthcare 的持股增加了 207.0%。Squarepoint Ops LLC 目前持有 479,977 股公司股票，价值为 2,510,000 美元，此前在上个季度又购买了 323,656 股。Qube Research &amp; Technologies Ltd 在第二季度将其在 Aveanna Healthcare 的持股增加了 92.4%。Qube Research &amp; Technologies Ltd 目前持有 437,838 股公司股票，价值为 2,290,000 美元，此前在上个季度又购买了 210,288 股。Lazard Asset Management LLC 在第二季度收购了 Aveanna Healthcare 的新股份，价值约为 791,000 美元。最后，Ameriprise Financial Inc.在第二季度将其在 Aveanna Healthcare 的持股增加了 168.0%。Ameriprise Financial Inc.目前持有 145,982 股公司股票，价值为 763,000 美元，此前在上个季度又购买了 91,508 股。87.96% 的股票目前由机构投资者和对冲基金持有。</p>
</div><h2>Aveanna Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Aveanna Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings Inc 是一家多元化的居家护理平台公司，在美国提供儿童和成人医疗服务。其以患者为中心的护理交付平台使患者能够留在家中，减少对高成本护理环境（如医院或专业护理机构）的过度使用。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐阅读</h2>
</div><ul>
<li>Five stocks we like better than Aveanna Healthcare</li>
<li>Business Services Stocks Investing</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>About the Markup Calculator</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
<li>Stock Market Holidays 2022-2025 - Here’s When the NYSE and NASDAQ Will be Closed</li>
<li>Qualcomm Earnings Surprise Wall Street—Here’s What Q4 Could Deliver</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 Aveanna Healthcare</li>
<li>商业服务股票投资</li>
<li>分析师认为 e.l.f.的抛售是一个良好的买入时机</li>
<li>关于 Markup 计算器</li>
<li>T-Mobile 是最被低估的大型股——是买入时机吗？</li>
<li>2022-2025 年股市假期 - 纽约证券交易所和纳斯达克将何时关闭</li>
<li>高通财报让华尔街感到惊讶——第四季度可能会带来什么</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=AVAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Aveanna Healthcare 吗？</h2>
</div><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Aveanna Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄向客户推荐在更广泛的市场注意到之前购买……而 Aveanna Healthcare 并不在名单上。</p>
</div><p>While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Aveanna Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Aveanna Healthcare（NASDAQ 代码：AVAH）公布了财务业绩